Evopoint Biosciences Inc.
Clinical trials sponsored by Evopoint Biosciences Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for advanced cancers: experimental drug XNW28012 enters human trials Results expected Dec 2026 (estimated)
- New drug candidate takes aim at Hard-to-Treat pancreatic cancer Results expected May 2027 (estimated)